Arcutis Biotherapeutics, Inc. (ARQT)
25.16
-0.13
(-0.51%)
USD |
NASDAQ |
Oct 02, 16:00
25.16
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price to Book Value : 14.33 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 14.33 |
| October 01, 2026 | 14.40 |
| September 30, 2026 | 15.05 |
| September 29, 2026 | 15.23 |
| September 28, 2026 | 15.56 |
| September 25, 2026 | 15.33 |
| September 24, 2026 | 14.96 |
| September 23, 2026 | 15.02 |
| September 22, 2026 | 15.82 |
| September 21, 2026 | 14.78 |
| September 18, 2026 | 14.45 |
| September 17, 2026 | 15.07 |
| September 16, 2026 | 14.88 |
| September 15, 2026 | 13.39 |
| September 14, 2026 | 13.82 |
| September 11, 2026 | 13.60 |
| September 10, 2026 | 13.31 |
| September 09, 2026 | 13.57 |
| September 08, 2026 | 13.89 |
| September 04, 2026 | 13.61 |
| September 03, 2026 | 13.47 |
| September 02, 2026 | 13.58 |
| September 01, 2026 | 13.52 |
| August 31, 2026 | 13.65 |
| August 28, 2026 | 13.54 |
| Date | Value |
|---|---|
| August 27, 2026 | 14.16 |
| August 26, 2026 | 14.31 |
| August 25, 2026 | 14.15 |
| August 24, 2026 | 14.11 |
| August 21, 2026 | 14.28 |
| August 20, 2026 | 14.43 |
| August 19, 2026 | 15.07 |
| August 18, 2026 | 15.11 |
| August 17, 2026 | 14.58 |
| August 14, 2026 | 14.91 |
| August 13, 2026 | 14.71 |
| August 12, 2026 | 14.96 |
| August 11, 2026 | 14.93 |
| August 10, 2026 | 14.76 |
| August 07, 2026 | 14.40 |
| August 06, 2026 | 15.05 |
| August 05, 2026 | 15.43 |
| August 04, 2026 | 14.82 |
| August 03, 2026 | 14.77 |
| July 31, 2026 | 15.29 |
| July 30, 2026 | 15.94 |
| July 29, 2026 | 15.86 |
| July 28, 2026 | 16.18 |
| July 27, 2026 | 15.85 |
| July 24, 2026 | 15.57 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Insmed, Inc. | 32.02 |
| Emergent BioSolutions, Inc. | 0.9512 |
| Exelixis, Inc. | 7.882 |
| Puma Biotechnology, Inc. | 3.508 |
Price to Book Value Related Metrics
| PE Ratio | 121.49 |
| PS Ratio | 7.236 |
| Price to Free Cash Flow | 85.76 |
| Price | 25.16 |
| Earnings Yield | 0.82% |
| Market Cap | 3.160B |
| Operating PE Ratio | 98.02 |
| Normalized PE Ratio | 121.25 |